1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. KEROS THERAPEUTICS INC
Keros Therapeutics Inc XNAS: KROS

Keros Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Falling Comet
about

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet m...

Read More
11.23 0.24 (2.18%)
50.20% Fall from 52W High
6,451.0
XNAS Volume

XNAS 13 Mar, 2026 9:33 AM (EDT)

Watchlist

Portfolio

Alert
Durability score
Medium Financial Strength
50.0 / 100
Valuation Score
Affordable Valuation
75.2 / 100
Momentum Score
Technically Bearish
33.8 / 100
Falling Comet These stocks are medium quality with average financials. However, their weak momentum indicates low investor interest View Similar Embed DVM
Analyst Price Target
23
1Yr Price target upside is 101%
7 analysts

5

S

8

W

4

O

2

T

SWOT Analysis

Keros Therapeutics Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..